Brett W. Carter

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-3841-8352

发表论文 247 篇 · 总被引 10291 次 · h-index 46

代表论文

• Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study (2023 · The Lancet Digital Health · 被引 112)
• Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial (2023 · Journal for ImmunoTherapy of Cancer · 被引 28)
• Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer (2024 · Journal for ImmunoTherapy of Cancer · 被引 9)
• Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC (2025 · Nature Communications · 被引 8)
• ACR Appropriateness Criteria® Sepsis (2024 · Journal of the American College of Radiology · 被引 4)
• Advancing the Collaboration Between Imaging and Radiation Oncology (2024 · Seminars in Radiation Oncology · 被引 3)